S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2024

BVF Partners

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$3.42B
Total portfolio value
Positions
55
Reported securities
Top Holding
MLTX
32.1% $1.10B
QoQ Changes
+5 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.10B32.08%$50.42$18.95-62.4%
32.1%
KYMRKYMERA THERAPEUTICS INC$244.3M7.15%$47.33$113.51+139.8%
7.2%
RVMDREVOLUTION MEDICINES INC$157.8M4.61%$45.35$189.24+317.3%
4.6%
MIRMMIRUM PHARMACEUTICALS INC$120.0M3.51%$39.00$125.59+222.0%
3.5%
TYRATYRA BIOSCIENCES INC$109.6M3.21%$23.51$30.62+30.2%
3.2%
OLMAOLEMA PHARMACEUTICALS INC$109.1M3.19%$11.94$12.64+5.9%
3.2%
GPCRSTRUCTURE THERAPEUTICS INC$98.3M2.87%$43.89$53.45+21.8%
2.9%
CGEMCULLINAN THERAPEUTICS INC$96.3M2.82%$16.74$17.63+5.3%
2.8%
XOMAXOMA ROYALTY CORPORATION$96.2M2.81%$26.48$43.00+62.4%
2.8%
AXSMAXSOME THERAPEUTICS INC$94.0M2.75%$89.87$244.31+171.8%
2.8%
PTGXPROTAGONIST THERAPEUTICS INC$83.3M2.44%$45.00$131.62+192.5%
2.4%
FDMT4D MOLECULAR THERAPEUTICS IN$79.8M2.33%$10.81$13.00+20.3%
2.3%
ACIUAC IMMUNE SA$73.8M2.16%$3.78$2.51-33.6%
2.2%
GHRSGH RESEARCH PLC$69.6M2.04%$6.69$27.01+303.7%
2.0%
KURAKURA ONCOLOGY INC$65.9M1.93%$19.54$11.10-43.2%
1.9%
THRDTHIRD HARMONIC BIO INC$59.2M1.73%β€”β€”
1.7%
IONSIONIS PHARMACEUTICALS INC$58.2M1.70%$40.06$81.80+104.2%
1.7%
ZYMEZYMEWORKS INC$57.8M1.69%$12.55$26.31+109.6%
1.7%
EPIXESSA PHARMA INC$53.0M1.55%β€”β€”
1.6%
AGIOAGIOS PHARMACEUTICALS INC$52.9M1.55%$44.43$37.58-15.4%
1.6%
CELCCELCUITY INC$51.7M1.51%$14.91$107.95+624.0%
1.5%
ETNB89BIO INC$50.4M1.47%β€”β€”
1.5%
FHTXFOGHORN THERAPEUTICS INC$49.4M1.44%$9.31$5.30-43.1%
1.4%
LKFTGALAPAGOS NV$45.2M1.32%$28.79$30.39+5.6%
1.3%
IDYAIDEAYA BIOSCIENCES INC$44.7M1.31%$31.68$37.65+18.8%
1.3%
ANNXANNEXON INC$41.4M1.21%$5.92$5.46-7.8%
1.2%
CGONCG ONCOLOGY INC$37.5M1.10%$37.73$70.36+86.5%
1.1%
RPTXREPARE THERAPEUTICS INC$35.5M1.04%β€”β€”
1.0%
NAMSNEWAMSTERDAM PHARMA COMPANY$25.3M0.74%$16.60$34.83+109.8%
0.7%
XNCRXENCOR INC$17.1M0.50%$20.11$15.00-25.4%
0.5%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (5)

TickerIssuerNotionalSince Filing
XNCRXENCOR INC$17.1M-25.4%
AVTXAVALO THERAPEUTICS INC$9.2M
TENXTENAX THERAPEUTICS INC$1.2M
NLSPNLS PHARMACEUTICS LTD$0.7M
FBRXFORTE BIOSCIENCES INC$0.7M

Exited Positions (8)

TickerIssuerNotional
MRUSMERUS N V$75.7M
CALTCALLIDITAS THERAPEUTICS AB$29.2M
ROIVROIVANT SCIENCES LTD$29.0M
JANXJANUX THERAPEUTICS INC$18.5M
VIRXVIRACTA THERAPEUTICS INC$2.0M
FBRXFORTE BIOSCIENCES INC$1.6M
NLSPNLS PHARMACEUTICS LTD$1.3M
UNCYUNICYCIVE THERAPEUTICS INC$1.1M

Increased (6)

TickerIssuerNotionalShares Ξ”Since Filing
CDTXCIDARA THERAPEUTICS INC$3.5M+104.9%
FDMT4D MOLECULAR THERAPEUTICS IN$-2.5M+88.2%+20.3%
ELEVELEVATION ONCOLOGY INC$-4.5M+28.3%
IDYAIDEAYA BIOSCIENCES INC$3.9M+21.3%+18.8%
AXSMAXSOME THERAPEUTICS INC$17.1M+9.5%+171.8%
ACIUAC IMMUNE SA$-1.4M+3.7%-33.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CGONCG ONCOLOGY INC$-38.8M-58.9%+86.5%
IONSIONIS PHARMACEUTICALS INC$-93.7M-54.4%+104.2%
PTGXPROTAGONIST THERAPEUTICS INC$-31.8M-44.3%+192.5%
RVMDREVOLUTION MEDICINES INC$-74.4M-41.8%+317.3%
MIRMMIRUM PHARMACEUTICALS INC$-29.4M-29.6%+222.0%
ZYMEZYMEWORKS INC$7.9M-21.5%+109.6%
KURAKURA ONCOLOGY INC$-18.2M-17.4%-43.2%
ETNB89BIO INC$-10.2M-10.0%
← Back to Hedge Funds